Image may be NSFW.
Clik here to view.
Western drugmakers aren’t the only ones building new plants in China. Taiwan’s ScinoPharm has just finished up a $113 million facility to make active pharmaceutical ingredients (APIs) for China, as well as for export to the U.S. and Europe.
Image may be NSFW.
Clik here to view.
Filed under: COMPANIES Tagged: API, ScinoPharm Image may be NSFW.
Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
Image may be NSFW.Clik here to view.
